使用晶体联合聚合技术解决瓦尔萨坦药物粉体流量不良问题
Madan Mohan Gupta1, Arindam Chatterjee2, Tarachand Kumawat3
1School of Pharmacy, Faculty of Medical Sciences, The University of the West Indies, St. Augustine, TTO.
Cureus
|June 8, 2023
概括
瓦尔萨坦是一种无形的抗高血压药物,已成功转化为球状晶体,以改善制药片制造的粉末流量. 优化的工艺产生了球形瓦尔萨坦晶体,其静止角度得到了改善,从而提高了药片生产的可行性.
科学领域:
- 制药科学 制药科学
- 材料科学 材料科学 材料科学
- 化学工程是化学工程的重要组成部分.
背景情况:
- 药物片是一种普遍存在的固体剂型,因易于使用和具有成本效益的制造而受到青.
- 无形药物粉末,如瓦尔萨坦,往往表现出不良的流动性 (静止角度> 40o),需要颗粒化以制备片剂.
- 改善粉末流量对于稳定的药片制造和药物疗效至关重要.
研究的目的:
- 为了将无形瓦尔萨坦转化为球形晶体,以提高其用于制药片制造的流动性.
- 为了优化工艺参数,以便有效地颗粒瓦尔萨坦.
- 为了评估准备好的球形瓦尔萨坦晶体的流量特性.
主要方法:
- 瓦尔萨坦药物粉末使用颗粒化技术加工成球形晶体.
- 包括混合速度,混合时间和温度在内的关键过程参数被系统地优化.
- 测量了静止角度,以评估准备好的球形晶体的流动特性.
主要成果:
- 这项研究成功地产生了瓦尔萨坦的球形晶体.
- 过程参数的优化导致无形药物的有效颗粒化.
- 最后一批球形瓦尔萨坦晶体的静止角度显著减少,为27.23o,表明出色的流动性.
结论:
- 球形结晶是一种有效的方法,可以改善无形瓦尔萨坦的流动性.
- 优化的工艺产生了适合制药片制造的瓦尔萨坦球形晶体.
- 这种方法解决了将无形药物制成固体剂型的挑战.
更多相关视频
07:26Improving High Viscosity Extrusion of Microcrystals for Time-resolved Serial Femtosecond Crystallography at X-ray Lasers
Published on: February 28, 2019
9.1K
10:12Flash NanoPrecipitation for the Encapsulation of Hydrophobic and Hydrophilic Compounds in Polymeric Nanoparticles
Published on: January 7, 2019
22.2K
相关概念视频
Colloidal precipitates
629
The high insolubility of some precipitates can result in an unfavorable relative supersaturation. This can lead to colloidal particles with a large surface-to-mass ratio, where adsorption is promoted. For instance, in the precipitation of silver chloride, silver ions are adsorbed on the surface of the colloidal particles, forming a primary layer. This layer attracts ions of opposite charge (such as nitrate ions), forming a diffuse secondary layer of adsorbed ions. This electric double layer...
629
Recrystallization: Solid–Solution Equilibria
1.1K
Recrystallization is a purification technique used to separate impurities from solid compounds. In this technique, no chemical reactions occur. Instead, it exploits physical properties only, specifically, the solubility differences between the desired compound and impurities, either at a single temperature or at different temperatures, and under other selected conditions. The solid-solution equilibrium (solubility equilibrium) of each component in the solution represents a binary phase...
1.1K
